Home | Site Map | Contact Us |  Tell a Colleague | Print Page  
Zenapax Roche
About Roche Transplantation Research Resources for Professionals Prescribing Information Community Support Industry Events/News
Sign Up
Login Here
E-mail
Password
Forgot Password

Important Safety and Prescribing Information

CellCept Zenapax Valcyte Learn More about Cellcept

Drug Interactions 

Click here for complete product information for ZENAPAX® (daclizumab).

The following medications have been administered with ZENAPAX in clinical trials in renal allograft patients with no incremental increase in adverse reactions:5

  • Cyclosporine
  • Mycophenolate mofetil
  • Ganciclovir
  • Acyclovir
  • Azathioprine
  • Corticosteroids

Very limited experience exists in these patients with the use of ZENAPAX concomitantly with the following medications:5

  • Tacrolimus
  • Muromonab-CD3
  • Antithymocyte globulin
  • Anti-lymphocyte globulin

  Safety Information

 

Reference:

5ZENAPAX® [product information]. Nutley, NJ: Roche Laboratories Inc.; September 2005.
Privacy Statement  |  Legal Statement  |  Intended for U.S. Physician Audiences Only Copyright © 2006-2008 - Roche Laboratories Inc. All rights reserved.